GS, C., S, P., L, M., C, J., R, G., S, V., . . . AS, W. (2021). Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: The STOP-HCV-1 non-inferiority, factorial RCT. https://doi.org/10.3310/eme08170
Chicago Style (17th ed.) CitationGS, Cooke, et al. Variable Short Duration Treatment Versus Standard Treatment, with and Without Adjunctive Ribavirin, for Chronic Hepatitis C: The STOP-HCV-1 Non-inferiority, Factorial RCT. 2021. https://doi.org/10.3310/eme08170.
MLA (9th ed.) CitationGS, Cooke, et al. Variable Short Duration Treatment Versus Standard Treatment, with and Without Adjunctive Ribavirin, for Chronic Hepatitis C: The STOP-HCV-1 Non-inferiority, Factorial RCT. 2021. https://doi.org/10.3310/eme08170.
